Research
At MiceCraft, we are pioneering AI-driven bioinformatics research, focusing on genomic data analysis and cancer biomarker discovery.
Cancer biomarkers are measurable indicators found in biological samples, such as blood, tissue, or genetic material, that provide critical insights into cancer development, progression, and treatment response.
These biomarkers can be genetic mutations, protein expressions, or metabolic signatures that help in early cancer detection, risk assessment, and personalized treatment strategies.
Genomic data includes DNA, RNA, and other molecular information that reveals the biological mechanisms underlying human health and disease. By analysing sequencing data, gene expression profiles, and mutation patterns, researchers can uncover key genomic alterations associated with cancer initiation, progression, and therapeutic response.
At MiceCraft, we integrate multi-omics datasets with advanced computational methods to transform complex genomic information into actionable biological insights. This enables more accurate disease stratification, target discovery, and biomarker identification for precision medicine.
Artificial intelligence enhances bioinformatics by identifying hidden patterns within large-scale biological datasets that are often difficult to detect through conventional analysis alone. Machine learning and data-driven modelling can improve the interpretation of genomic variation, predict clinically relevant biomarkers, and support more robust decision-making in translational research.
Our AI-driven pipelines are designed to accelerate discovery while maintaining scientific rigour and reproducibility. By combining computational intelligence with biological expertise, we help turn raw data into meaningful insights for cancer research and biomarker development